Density functional theory |
Doxorubicin, daunorubicin |
Physicochemical properties, binding energy |
Qualitative |
Carrier-drug affinity, surface modification effects |
Rahimi et al., 2012 |
Molecular dynamics |
Curcumin, prednisolone, resveratrol |
Binding energy |
>85% |
Carrier–drug affinity |
Metwally and Hathout, 2015 |
Molecular dynamics |
Oxaliplatin |
Density Glass transition temperature |
>96% >95% |
Polymer degradation, drug release |
Lange et al., 2016 |
Molecular dynamics, computational fluid dynamics, coarse grain |
None |
Shear stress, lipid-PLGA interaction energy |
Qualitative |
Loading capacity, release kinetics |
Salvador-Morales et al., 2016 |
Finite element analysis |
Rhodamine B |
Diffusion, drug release |
Qualitative |
Polymer degradation, drug release |
Milosevic et al., 2018 |
Molecular dynamics |
Itraconazole |
Binding energy |
Qualitiative |
Drug loading ability of carrier |
Wilkosz et al., 2018 |
Molecular dynamcs |
Melittin |
Binding energy, radial distribution function |
None |
Protein-peptide interactions, encapsulation affinity |
Asadzadeh and Moosavi, 2019 |